Edelmann, J., & Zenz, T. (2014). High resolution genomic profiling of primary "Ultra high risk" and refractory chronic lymphocytic leukemia: Results from the CLL2O trial. Blood, 124(21), .
Chicago Style (17th ed.) CitationEdelmann, Jennifer, and Thorsten Zenz. "High Resolution Genomic Profiling of Primary "Ultra High Risk" and Refractory Chronic Lymphocytic Leukemia: Results from the CLL2O Trial." Blood 124, no. 21 (2014).
MLA (9th ed.) CitationEdelmann, Jennifer, and Thorsten Zenz. "High Resolution Genomic Profiling of Primary "Ultra High Risk" and Refractory Chronic Lymphocytic Leukemia: Results from the CLL2O Trial." Blood, vol. 124, no. 21, 2014.
Warning: These citations may not always be 100% accurate.